Strategies for Tranfusing Patients with a Positive DAT (by CACMLE) (Online Course)

Phyllis S. Walker, MS, MT(ASCP)SBB

See all available courses »

Continuing Education Credits

Objectives

  • List 3 techniques for determining the phenotype of a patient with a positive DAT.
  • Contrast the differences between autologous and allogeneic adsorptions.
  • Describe 3 strategies for providing safe transfusions for patients with a positive DAT.

Course Outline

  • PowerPoint Slides
      • Strategies for Transfusing Patients with a Positive DAT
      • Author
      • Learning Objectives
      • Antibody Identification with a Positive Autocontrol
      • Direct Antiglobulin Test
      • Direct Antiglobulin Test, cont.
      • Autocontrol
      • Autocontrol vs. DAT
      • Causes of a Positive Autocontrol
      • Positive Autocontrol & Negative DAT
      • Positive Autocontrol & Negative DAT, cont.
      • Causes of a Positive DAT (+DAT)
      • +DAT: Initial Testing
      • +DAT: Initial Testing, cont.
      • WARM-treated RBCs
      • +DAT: Initial Testing (recently transfused)
      • +DAT: Initial Testing (recently transfused), cont.
      • +DAT: Initial Testing (recently transfused), cont.
      • +DAT: No RBCs reactive with serum or eluate
      • Drug-induced Antibody
      • +DAT: Some RBCs reactive with serum or eluate
      • +DAT: All RBCs reactive with serum or eluate
      • +DAT: All RBCs reactive with serum or eluate (not recently transfused)
      • +DAT: All RBCs reactive with serum or eluate (recently transfused)
      • +DAT: All RBCs reactive with serum or eluate (recently transfused), cont.
      • +DAT: Serum is reactive, Eluate is nonreactive
      • +DAT: Serum is nonreactive, Eluate is reactive
      • "The Problem"
      • "The Problem, cont. "
      • Strategies . . .
      • Strategies, cont. . . .
      • Strategies, cont. . . .
      • Strategies, cont. . . .
      • Strategies, cont. . . .
      • Strategies, cont. . . .
      • The End



Slide 2


Slide 15


Slide 20


Slide 28